Review of Obesity Treatment and Devices

The emergence of several innovative FDA-approved obesity treatment devices may offer an additional therapeutic option for adults seeking obesity care. Designed to mimic the effects of restrictive and bypass surgeries, preliminary data suggest that obesity treatment devices typically produce 10-20% weight loss at one year that may be accompanied by significant metabolic improvement.

Maternal-Child Intergenerational Transmission of Obesity

A growing body of evidence indicates that obesity has a detrimental impact on reproductive potential in women. In addition to reduced fertility, maternal pre-pregnancy body mass index (BMI), excessive gestational weight gain, and postpartum weight retention are collectively associated with adverse fetal development, obstetric complications, and long-term health outcomes for mothers and their offspring.

Obesity & Non-Nutritive Sweeteners infographic

Obesity & Non-Nutritive Sweeteners Infographic

Obesity and Non-Nutritive Sweeteners - Are these popular sugar alternatives part of the problem or the solution?

Obesity & Liver Disease infographic

Obesity & Liver Disease Infographic

Non-alcoholic fatty liver disease (NAFLD) affects 1 in 3 U.S. adults... and it's a cause for concern.

Distribution of Health Providers for Severe Obesity

Treatment Providers for Severe Obesity - It takes a village: promote provider training and collaboration to improve access.

Infographic: Excessive Weight Gain Among Adolescents - Thumbnail

Excessive Weight Gain Among Young Adults

A New Target for Prevention – The rising in obesity prevalence between the ages of 6-11 years and 20-39 years - from 17 to 34 percent - indicates that the transition from childhood to young adulthood is a critical window for obesity prevention and control efforts.